Cosmos Holdings Inc. (COSM) |
|
0.4939 0.065 (15.13%)
|
11-28 10:33 |
|
Open: |
0.498 |
Pre. Close: |
0.429 |
|
High:
|
0.5317 |
Low:
|
0.4633 |
|
Volume:
|
73,298,346 |
Market Cap:
|
41(M) |
|
|
|
Technical analysis |
as of: 2022-11-28 10:17:38 AM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 0.77 One year: 0.9 |
| Support: |
Support1: 0.29 Support2: 0.06 |
| Resistance: |
Resistance1: 0.66 Resistance2: 0.77 |
| Pivot: |
0.19  |
| Moving Average: |
MA(5): 0.34 MA(20): 0.16
MA(100): 0.27 MA(250): 1.42  |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 57.9 %D(3): 67.1 |
| RSI: |
RSI(14): 86 |
| 52-week: |
High: 4.44 Low: 0.06 |
| Average Vol(K): |
3-Month: 31,408 (K) 10-Days: 129,261 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ COSM ] has closed above the upper band by 7.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 268% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.48 - 0.48 |
0.48 - 0.48 |
|
Low:
|
0.36 - 0.36 |
0.36 - 0.36 |
|
Close:
|
0.43 - 0.43 |
0.43 - 0.43 |
|
Company Description |
|
Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. The company was formerly known as Prime Estates and Developments, Inc. and changed its name to Cosmos Holdings Inc. in November 2013. Cosmos Holdings Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois. |
Headline News |
Fri, 25 Nov 2022
Cosmos Holdings (COSM) Stock Rose 42%+ Despite Lack of News - AskTraders
Wed, 23 Nov 2022
Entertainment Retailer Plans Second Venue, Eyes U.S. Expansion - Bisnow
Wed, 23 Nov 2022
The Lakeside Journal Business Briefs: Cosm, city board applications, and more - Star Local Media
Tue, 22 Nov 2022
Thinking about buying stock in Obseva SA, Cosmos Holdings, Alibaba, American Eagle Outfitters, or TJX Companies? - PR Newswire
Mon, 21 Nov 2022
Monday's NASDAQ Alert +42% and Big Gains in MMAT MMTLP COSM - Insider Financial
Mon, 21 Nov 2022
Cosmo Coin (COSM) has a Very Bearish Sentiment Score, is Falling, and Underperforming the Crypto Market Monday: What's Next? - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
84 (M) |
| Shares Float |
18 (M) |
|
% Held by Insiders
|
135.1 (%) |
|
% Held by Institutions
|
0.7 (%) |
|
Shares Short
|
5,830 (K) |
|
Shares Short P.Month
|
742 (K) |
Stock Financials |
|
EPS
|
-1.12 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0.12 |
|
Profit Margin (%)
|
-8.3 |
|
Operating Margin (%)
|
-1.3 |
|
Return on Assets (ttm)
|
-1 |
|
Return on Equity (ttm)
|
-91.5 |
|
Qtrly Rev. Growth
|
-11.7 |
|
Gross Profit (p.s.)
|
0.09 |
|
Sales Per Share
|
0.64 |
|
EBITDA (p.s.)
|
-0.01 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-6 (M) |
|
Levered Free Cash Flow
|
11 (M) |
Stock Valuations |
|
PE Ratio
|
-0.44 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
3.72 |
|
Price to Sales
|
0.74 |
|
Price to Cash Flow
|
-6.7 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
